Patent · US Active

Bacteria engineered to treat a disease or disorder

US10933102B2 · kind B2 · utility

7Cited by

3References

22Claims

0Family size

Assignee

Synlogic Operating Company, Inc. · US

Inventors

Dean Falb · Sherborn, US
Paul F. Miller · Salem, US
Jonathan W. Kotula · Somerville, US
Vincent M. Isabella · Medford, US
Suman Machinani · Cambridge, US
Adam B. Fisher · Cambridge, US
Yves Millet · Newton, US

Key dates

Filing date	Dec 22, 2017
Grant date	Mar 2, 2021
Priority date	—
Expiry date	Dec 22, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically programmed microorganisms, such as bacteria, pharmaceutical compositions thereof, and methods of modulating and treating a disease and/or disorder are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.